Zidovudine and Volvulus - a phase IV clinical study of FDA data

Summary:

Volvulus is reported as a side effect among people who take Zidovudine (zidovudine), especially for people who are male, 0-1 old, have been taking the drug for 1 - 2 years also take Lamivudine, and have Hiv infection.

The phase IV clinical study analyzes which people have Volvulus when taking Zidovudine. It is created by eHealthMe based on reports of 10,506 people who have side effects when taking Zidovudine from the FDA, and is updated regularly.

What is Zidovudine?

Zidovudine has active ingredients of zidovudine. eHealthMe is studying from 10,517 Zidovudine users. Check the latest studies of Zidovudine.

What is Volvulus?

Volvulus (obstruction caused by twisting of the stomach or intestine) is found to be associated with 279 drugs and 374 conditions by eHealthMe. Check the latest studies of Volvulus.

On Jul, 10, 2026

10,506 people reported to have side effects when taking Zidovudine.
Among them, 76 people (0.72%) have Volvulus.

Among these 76 people:

How long have people been on Zidovudine when they have Volvulus? *

What is the gender of people who have Volvulus when taking Zidovudine? *

female: 1.59 %
male: 98.41 %

What is the age of people who have Volvulus when taking Zidovudine? *

What are other drugs people take besides Zidovudine? *

Lamivudine: 75 people, 98.68%
Nevirapine: 68 people, 89.47%
Isentress: 67 people, 88.16%
Kaletra: 62 people, 81.58%
Viramune: 46 people, 60.53%
Raltegravir: 45 people, 59.21%
Viread: 45 people, 59.21%
Tenofovir Disoproxil Fumarate: 37 people, 48.68%
Ritonavir: 34 people, 44.74%
Lopinavir And Ritonavir: 9 people, 11.84%

What are other side effects people have besides Volvulus? *

Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 65 people, 85.53%
Aspartate Aminotransferase Increased: 8 people, 10.53%
Alanine Aminotransferase Increased: 8 people, 10.53%
Maternal Exposure During Pregnancy (use of substance during pregnancy): 4 people, 5.26%
Drug Exposure During Pregnancy: 2 people, 2.63%
Trisomy 18 (a genetic disorder caused by the presence of all or part of an extra 18th chromosome): 1 person, 1.32%
Speech Disorder Developmental: 1 person, 1.32%
Intestinal Malrotation (congenital anomaly of rotation of the midgut): 1 person, 1.32%
Hydrops Foetalis (fetus characterized by an accumulation of fluid): 1 person, 1.32%
Developmental Delay: 1 person, 1.32%

What are the existing conditions these people have? *

Hiv Infection: 48 people, 63.16%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 41 people, 53.95%
Maternal Exposure During Pregnancy (use of substance during pregnancy): 3 people, 3.95%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 3 people, 3.95%

* Approximation only. Some reports may have incomplete information.

Do you take Zidovudine and have Volvulus?

- Check whether Volvulus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zidovudine:

Zidovudine (10,517 reports)

Volvulus treatments and more:

Volvulus (2,613 reports)

Browse all side effects of Zidovudine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Volvulus:

Volvulus (279 drugs)

Browse all the conditions that are associated with Volvulus:

Volvulus (374 conditions)

Related publications that referenced our studies

Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .
Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on zidovudine (the active ingredients of Zidovudine) and Zidovudine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.